DE68925505D1 - Zusammensetzungen zum Erreichen eines Lasereffektes und Methoden zu deren Gebrauch - Google Patents

Zusammensetzungen zum Erreichen eines Lasereffektes und Methoden zu deren Gebrauch

Info

Publication number
DE68925505D1
DE68925505D1 DE68925505T DE68925505T DE68925505D1 DE 68925505 D1 DE68925505 D1 DE 68925505D1 DE 68925505 T DE68925505 T DE 68925505T DE 68925505 T DE68925505 T DE 68925505T DE 68925505 D1 DE68925505 D1 DE 68925505D1
Authority
DE
Germany
Prior art keywords
achieving
compositions
methods
variety
laser effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68925505T
Other languages
English (en)
Other versions
DE68925505T2 (de
Inventor
Joseph H Boyer
Lee Roy Morgan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exciton Inc Dayton Ohio Us
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22950859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE68925505(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of DE68925505D1 publication Critical patent/DE68925505D1/de
Application granted granted Critical
Publication of DE68925505T2 publication Critical patent/DE68925505T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/08—Copper compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/02—Magnesium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/06—Zinc compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/022—Boron compounds without C-boron linkages
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00—Other synthetic dyes of known constitution
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01S—DEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL
    • H01S3/00—Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range
    • H01S3/14—Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range characterised by the material used as the active medium
    • H01S3/20—Liquids
    • H01S3/213—Liquids including an organic dye

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Electromagnetism (AREA)
  • Materials Engineering (AREA)
  • Plasma & Fusion (AREA)
  • Optics & Photonics (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE68925505T 1988-09-29 1989-09-28 Zusammensetzungen zum Erreichen eines Lasereffektes und Methoden zu deren Gebrauch Expired - Fee Related DE68925505T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/251,188 US4916711A (en) 1988-09-29 1988-09-29 Lasing compositions and methods for using the same

Publications (2)

Publication Number Publication Date
DE68925505D1 true DE68925505D1 (de) 1996-03-07
DE68925505T2 DE68925505T2 (de) 1996-09-12

Family

ID=22950859

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68925505T Expired - Fee Related DE68925505T2 (de) 1988-09-29 1989-09-28 Zusammensetzungen zum Erreichen eines Lasereffektes und Methoden zu deren Gebrauch

Country Status (5)

Country Link
US (1) US4916711A (de)
EP (1) EP0361936B1 (de)
JP (1) JP2880534B2 (de)
AT (1) ATE133418T1 (de)
DE (1) DE68925505T2 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5433896A (en) * 1994-05-20 1995-07-18 Molecular Probes, Inc. Dibenzopyrrometheneboron difluoride dyes
US5274113A (en) * 1991-11-01 1993-12-28 Molecular Probes, Inc. Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates
US5326692B1 (en) * 1992-05-13 1996-04-30 Molecular Probes Inc Fluorescent microparticles with controllable enhanced stokes shift
US5723218A (en) * 1990-04-16 1998-03-03 Molecular Probes, Inc. Dipyrrometheneboron difluoride labeled flourescent microparticles
US5446157A (en) * 1990-04-23 1995-08-29 Morgan; Lee R. Boron difluoride compounds useful in photodynamic therapy and production of laser light
US5220009A (en) * 1990-05-03 1993-06-15 Yeda Research And Development Company Limited Phenothiazinium salts and their use for disinfecting aqueous effluents
US5248782A (en) * 1990-12-18 1993-09-28 Molecular Probes, Inc. Long wavelength heteroaryl-substituted dipyrrometheneboron difluoride dyes
US5338854A (en) * 1991-02-13 1994-08-16 Molecular Probes, Inc. Fluorescent fatty acids derived from dipyrrometheneboron difluoride dyes
US5187288A (en) * 1991-05-22 1993-02-16 Molecular Probes, Inc. Ethenyl-substituted dipyrrometheneboron difluoride dyes and their synthesis
US5308544A (en) * 1992-02-28 1994-05-03 Beckman Instruments, Inc. Liquid scintillation solution useful for alpha particle emission and beta particle emission discrimination
US5986093A (en) * 1995-06-07 1999-11-16 Carnegie Mellon University Monomethine cyanines rigidized by a two-carbon chain
US5852191A (en) 1995-06-07 1998-12-22 Carnegie Mellon University Rigidized monomethine cyanines
US5869689A (en) * 1995-10-17 1999-02-09 Molecular Probes, Inc Stains for acidic organelles
US5948593A (en) * 1996-07-29 1999-09-07 Mitsui Chemicals, Inc. Optical recording medium
US5786219A (en) * 1996-10-28 1998-07-28 Molecular Probes, Inc. Microspheres with fluorescent spherical zones
US6106999A (en) * 1997-08-12 2000-08-22 Mitsui Chemicals Photosensitizer, visible light curable resin composition using the same, and use of the composition
GB2344688A (en) 1998-12-08 2000-06-14 Secr Defence Organic light emitting diode device
ES2161152B1 (es) * 1999-07-09 2002-07-01 Consejo Superior Investigacion Nuevos polimeros portadores en su estructura de colorantes dipirrometinicos y su utilizacion como laseres.
EP1492799B1 (de) 2002-03-22 2013-09-11 HAE Therapeutics Limited Verbindungen die als photodynamische mitteln anwendbar sind
US20040062947A1 (en) * 2002-09-25 2004-04-01 Lamansky Sergey A. Organic electroluminescent compositions
US7300709B2 (en) * 2004-03-31 2007-11-27 Eastman Kodak Company Organic element for electroluminescent devices
ES2454551T3 (es) * 2004-12-28 2014-04-10 Gemin X Pharmaceuticals Canada Inc. Compuestos dipirrólicos, composiciones, y métodos para el tratamiento del cáncer o enfermedades virales
US20070091967A1 (en) 2005-10-06 2007-04-26 Xiaoming Tao Laser emitting material, method for making the same and use thereof
WO2009025767A1 (en) * 2007-08-17 2009-02-26 Research Foundation Of The City University Of New York Boron dipyrromethene difluoro (bodipy) conjugates
KR100948853B1 (ko) 2007-11-16 2010-03-22 삼성모바일디스플레이주식회사 헤테로고리 화합물 및 이를 이용한 유기 전계 발광 장치
KR100981968B1 (ko) * 2007-11-16 2010-09-13 삼성모바일디스플레이주식회사 헤테로고리 화합물 및 이를 이용한 유기 전계 발광 장치
US20130020507A1 (en) 2010-06-17 2013-01-24 Life Technologies Corporation Methods for Detecting Defects in Inorganic-Coated Polymer Surfaces
EP2554975A1 (de) * 2007-12-17 2013-02-06 Life Technologies Corporation Verfahren und Substrat zum Erfassen von Defekten in anorganisch beschichteten Polymeroberflächen
MX2009013486A (es) * 2009-12-10 2011-06-14 Univ Guanajuato Sintesis de 8-aminoborodipirrometenos con fluorescencia azul.
KR100970399B1 (ko) * 2010-04-21 2010-07-15 삼성모바일디스플레이주식회사 헤테로고리 화합물 및 이를 이용한 유기 전계 발광 장치
JP2012127032A (ja) * 2010-12-16 2012-07-05 Fujifilm Corp 繊維染色用染料組成物および繊維材料
WO2012173575A1 (en) * 2011-06-15 2012-12-20 National University Of Singapore Alkylamino bodipy dyes as selective fluorescent probes for proteins and mouse embryonic stem cells
TWI557187B (zh) * 2012-05-03 2016-11-11 拜耳材料科學股份有限公司 用於光聚合物之新穎光起始劑
CN102702768B (zh) * 2012-06-04 2013-12-04 天津理工大学 一种新型红光bodipy荧光染料及其制备方法和应用
WO2015077427A1 (en) 2013-11-20 2015-05-28 The University Of Akron Highly Fluorescent Pyrrole-BF2 Chromophores
US9273078B2 (en) 2013-12-05 2016-03-01 The University Of Akron Half-phthalocyanine-like chelates and synthesis thereof
KR101968901B1 (ko) * 2015-02-06 2019-04-15 주식회사 엘지화학 색변환 필름, 및 이를 포함하는 백라이트 유닛 및 디스플레이 장치
US20160230960A1 (en) * 2015-02-06 2016-08-11 Lg Chem, Ltd. Color conversion film and back light unit and display apparatus comprising the same
EP3246331A1 (de) * 2016-05-16 2017-11-22 Rudjer Boskovic Institute Chinon methid vorstufen mit bodipy chromophor, herstellungsverfahren, biologische aktivität und anwendung in fluoreszenzmarkierung
KR102200716B1 (ko) 2016-11-30 2021-01-12 도레이 카부시키가이샤 피로메텐 붕소 착체, 색 변환 조성물, 색 변환 필름, 광원 유닛, 디스플레이 및 조명 장치
WO2018128195A1 (ja) 2017-01-06 2018-07-12 Hoya株式会社 キャリブレーション用固体試料、内視鏡システム、及び固体試料の作製方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0210351B1 (de) * 1985-04-30 1993-07-21 Nippon Petrochemicals Co., Ltd. Verwendung von Porphyrinderivaten bei der Entdeckung und Behandlung von Tumoren
CA1340951C (en) * 1986-01-02 2000-04-11 Alan R. Moragn Production and use of purpurins, chlorins and purpurin-and chlorin-containing compositions
US4774339A (en) * 1987-08-10 1988-09-27 Molecular Probes, Inc. Chemically reactive dipyrrometheneboron difluoride dyes
US4799230A (en) * 1987-11-20 1989-01-17 The United States Of America As Represented By The Secretary Of The Navy Laser dyes derived from bimanes

Also Published As

Publication number Publication date
EP0361936B1 (de) 1996-01-24
DE68925505T2 (de) 1996-09-12
JP2880534B2 (ja) 1999-04-12
EP0361936A2 (de) 1990-04-04
EP0361936A3 (de) 1991-04-03
JPH02196865A (ja) 1990-08-03
ATE133418T1 (de) 1996-02-15
US4916711A (en) 1990-04-10

Similar Documents

Publication Publication Date Title
DE68925505D1 (de) Zusammensetzungen zum Erreichen eines Lasereffektes und Methoden zu deren Gebrauch
ATE124405T1 (de) 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel.
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
ES2099686T1 (es) Composicion de aminoazucar y glicosaminoglicano para el tratamiento y reparacion de tejido conjuntivo.
DE69010139D1 (de) Haarkräftigungsmittel.
SE8602723D0 (sv) Thiazoles, their production and pharmaceutical compositions containing them
DE69623899D1 (de) Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen
RU94038064A (ru) Производные пиперазина и пиперидина, их применение в качестве противопсихотических средств, способ их получения фармацевтическая композиция
ATE107515T1 (de) Zusammensetzung zur behandlung von entzündung.
DE58900183D1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
ES2091766T3 (es) Uso de n-butil-desoxinojirimicina para el tratamiento de herpes.
PT96938A (pt) Processo para a preparacao de novos compostos 3-arilcarbonil-1-aminoalquil-1h- indol uteis como agentes antiglaucoma
ATE50571T1 (de) Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
FI945787A (fi) Sulfoniumsuoloja ja menetelmä niiden valmistamiseksi
ES2163396T3 (es) Aminas biologicamente activas.
ATE182586T1 (de) Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung
MX9401080A (es) Compuestos heteroaromaticos.
FI101597B1 (fi) Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa
ES2072975T3 (es) Mezcla de esterilizante y metodo de esterilizacion.
DK0655992T3 (da) Fluorenonderivater, fremgangsmåde til deres fremstilling samt regenererings- og beskyttelsesmiddel mod central eller perife
DE69002328D1 (de) Geminale bisphosphonsaeuren und deren derivate als antiarthritische mittel.
ATE120447T1 (de) Polyamin-derivate als antineoplastische mittel.
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
NO932502L (no) Nye fosfolipidderivater
DE69512313T2 (de) Pseudopeptidderivate der Neurokinine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BO-DEKK VENTURES, LTD., NEW ORLEANS, LA., US

8381 Inventor (new situation)

Free format text: BOYER, JOSEPH H., NEW ORLEANS, LOUISIANA 70119, US MORGAN, LEE ROY, NEW ORLEANS, LOUISIANA 70122, USHERR, JOSEPH H.BOYER, NEW ORLEANS, LA., US HERR, LEE ROY MORGAN, NEW ORLEANS, LA., US

Free format text: BOYER, JOSEPH H., NEW ORLEANS, LOUISIANA 70119, US MORGAN, LEE ROY, NEW ORLEANS, LOUISIANA 70122, US HERR, JOSEPH H.BOYER, NEW ORLEANS, LA., US HERR, LEE ROY MORGAN, NEW ORLEANS, LA., US

8327 Change in the person/name/address of the patent owner

Owner name: EXCITON, INC., DAYTON, OHIO, US

8339 Ceased/non-payment of the annual fee